Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

HAROLD ZILBERMAN MD CHARTERED

NPI: 1942364054 · LAS VEGAS, NV 89109 · Pediatrics Physician · NPI assigned 12/21/2006

$14.28M
Total Medicaid Paid
459,217
Total Claims
439,173
Beneficiaries
67
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialZILBERMAN, HAROLD (OWNER)
NPI Enumeration Date12/21/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 2,061 $94K
2019 78,532 $2.50M
2020 72,189 $2.20M
2021 79,618 $2.39M
2022 76,413 $2.50M
2023 83,868 $2.57M
2024 66,536 $2.02M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 50,533 47,234 $2.90M
90460 Immunization administration through 18 years of age via any route, first or only component 49,347 47,345 $2.59M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 29,999 28,394 $2.58M
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 19,896 17,947 $1.63M
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 18,198 17,715 $1.59M
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 11,925 11,604 $1.04M
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 5,028 4,890 $481K
99058 24,551 23,115 $424K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 3,948 3,707 $296K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 5,058 4,882 $95K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 7,611 7,337 $62K
90461 2,951 2,885 $61K
99383 629 599 $56K
94010 1,752 1,703 $49K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1,520 1,436 $48K
96110 Developmental screening, with scoring and documentation, per standardized instrument 6,644 6,484 $42K
83655 5,226 5,091 $41K
92567 3,406 3,114 $37K
36416 12,518 12,026 $33K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 692 669 $31K
99460 374 352 $30K
96127 5,993 5,771 $26K
99238 Hospital discharge day management, 30 minutes or less 379 354 $23K
99384 189 181 $19K
99381 203 181 $17K
99382 149 145 $13K
92587 33,881 32,936 $12K
85018 8,008 7,767 $12K
93000 828 799 $12K
99188 909 888 $11K
92015 Determination of refractive state 28,245 27,429 $10K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 57 54 $5K
0012A 154 135 $3K
87807 292 281 $2K
0011A 159 137 $2K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 12 12 $2K
99463 14 13 $1K
94667 34 27 $616.14
69210 27 26 $428.72
81002 153 148 $283.85
90671 4,044 3,759 $221.58
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 13 12 $196.68
99177 1,248 1,230 $188.85
90472 Immunization administration, each additional vaccine (list separately) 14 14 $154.14
90670 9,666 9,467 $96.14
A7003 Administration set, with small volume nonfiltered pneumatic nebulizer, disposable 34 27 $49.90
A7015 Aerosol mask, used with dme nebulizer 47 39 $46.48
90686 16,653 15,934 $33.52
90713 14,271 13,724 $22.26
90707 5,663 5,447 $19.27
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 47 39 $9.08
94760 21 15 $5.80
90685 1,645 1,606 $1.70
90680 8,214 7,924 $1.04
90651 2,533 2,433 $1.04
90744 6,785 6,546 $0.00
90716 5,695 5,484 $0.00
90619 626 589 $0.00
91301 285 242 $0.00
90656 867 860 $0.00
99000 61 60 $0.00
90648 13,751 13,277 $0.00
90700 17,644 16,986 $0.00
90633 6,537 6,327 $0.00
90734 859 835 $0.00
90715 489 471 $0.00
90710 13 13 $0.00